A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiative

Recent improvements in next-generation sequencing (NGS) technology have enabled detection of biomarkers in cell-free DNA in blood and may ultimately replace invasive tissue biopsies. However, a better understanding of the performance of blood-based NGS assays is needed prior to routine clinical use....

Descripción completa

Detalles Bibliográficos
Autores principales: Pishvaian, Michael J., Joseph Bender, R., Matrisian, Lynn M., Rahib, Lola, Hendifar, Andrew, Hoos, William A., Mikhail, Sam, Chung, Vincent, Picozzi, Vincent, Heartwell, Craig, Mason, Kimberly, Varieur, Katelyn, Aberra, Metasebia, Madhavan, Subha, Petricoin, Emanuel, Brody, Jonathan R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663527/
https://www.ncbi.nlm.nih.gov/pubmed/29137355
http://dx.doi.org/10.18632/oncotarget.13225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663527/
https://www.ncbi.nlm.nih.gov/pubmed/29137355
http://dx.doi.org/10.18632/oncotarget.13225

Ejemplares similares